Prepare for your visit
Rachel Gathro
Nurse Practitioner · North Salt Lake, UT · NPI 1619748464
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$507.40
in general payments reported to CMS, 2019-2025 · $507 in 2025
The $507 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Who reported paying
General payments only, top 6 by amount.
- Indivior INC. $135.15
- Astrazeneca Pharmaceuticals LP $99.89
- Abbvie INC. $51.97
- Novo Nordisk INC $33.08
- Bayer Healthcare Pharmaceuticals INC. $26.46
- Boston Scientific Corporation $21.32
Drugs and devices associated with these payments
Sublocade Vraylar Breztri Airsupra Wegovy Kerendia Farxiga Wavewriter Alpha Prime 16 Leqvio Kisunla Ingrezza Caplyta
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Rachel Gathro listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/11601077/rachel-gathro